4.4 Article

Sleep Management Among Patients with Substance Use Disorders

Journal

MEDICAL CLINICS OF NORTH AMERICA
Volume 102, Issue 4, Pages 733-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2018.02.012

Keywords

Sleep initiation and maintenance disorders; Substance-related disorders; Alcoholism; Cocaine-related disorders; Marijuana abuse; Opioid-related disorders

Funding

  1. AstraZeneca
  2. Teva Pharmaceuticals
  3. Zynerba Pharmaceuticals
  4. Insys Therapeutics Inc
  5. Battelle Memorial Institute
  6. several small US businesses engaged in state medicinal cannabis programs
  7. VA [IK2CX000855, U01 DA031784, R01 DA034261, R01 NR015977 R34 DA032800 R21 DA031369]

Ask authors/readers for more resources

Sleep and substance use disorders commonly co-occur. Insomnia is commonly associated with the use of and withdrawal from substances. Circadian rhythm abnormalities are being increasingly linked with psychoactive substance use. Other sleep disorders, such as sleep-related breathing disorder, should be considered in the differential diagnosis of insomnia, especially in those with opioid use or alcohol use disorder. Insomnia that is brief or occurs in the context of active substance use is best treated by promoting abstinence. A referral to a sleep medicine clinic should be considered for those with chronic insomnia or when another intrinsic sleep disorder is suspected.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available